Influx Healthtech IPO is opening for subscription from June 18 to June 20, 2025. The company plans to raise ₹499.60 crores through a fresh issue, and the listing will be on the NSE SME platform. The company operates in the fast-growing contract development and manufacturing (CDMO) sector, providing development and manufacturing services to nutraceutical, cosmetic, veterinary, and homecare brands.
Founded in 2020, the company has 3 manufacturing units in Maharashtra and offers a wide range of products like tablets, gummies, skincare items, oral dispersible films, and more, catering to various industries. A diversified product portfolio, an expanding client base, and a year-on-year increase in revenue, the IPO has created a buzz among investors.
Influx Healthtech IPO Details
| IPO Name | Influx Healthtech IPO |
| IPO Open and Close Date | June 18, 2025 to June 20, 2025 |
| Issue Price Band | ₹91 to ₹96 per share |
| Lot Size | 1,200 Shares |
| Listing At | NSE SME |
| Issue Size | ₹55.63 crores |
| Issue Type | Fresh Issue & OFS |
| Allotment Date | June 23, 2025 |
| Listing Date | June 25, 2025 |
| Retail Investors Minimum Lot & Amount | 1 lot & ₹1,15,200 |
| Retail Investors Maximum Lot & Amount | 1 lot & ₹1,15,200 |
| HNIs Minimum Lot & Amount | 2 lots & ₹2,30,400 |
Influx Healthtech IPO – FAQs
1. What is the open and close dates for the Influx Healthtech IPO?
The open and close dates for Influx Healthtech IPO is June 18, 2025 to June 20, 2025.
2. What is the price band and lot size?
The price band is ₹91 to ₹96 per share and 1 lot comprises 1200 shares.
3. Where will the Influx Healthtech IPO be listed?
The IPO will be listed on NSE SME platform.
4. What is the size and type of the issue?
The size of the issue is ₹55.63 crores, and it will be a Fresh issue.
5. What is the allotment and listing date?
The shares will be allotted on June 23, 2025 and listed on the NSE SME platform on June 25, 2025.
6. What is the lot size and amount for retail and HNI investors?
The minimum and maximum lot size and amount for retail investors is 1 lot & ₹1,15,200, while HNI can invest a minimum of 2 lots & ₹2,30,400.
8. What does Influx Healthtech do?
The company offers end-to-end contract development and manufacturing (CDMO) services, for:
-
Nutraceutical and herbal supplements
-
Cosmetics and skincare products
-
Veterinary feed supplements
-
Homecare solutions
9. Where are its manufacturing facilities located?
All three facilities are located in Thane, Maharashtra.
10. How has the company performed financially?
Here’s a summary of their financial growth:
| Year | Revenue (₹ Cr) | PAT (₹ Cr) | Assets (₹ Cr) |
|---|---|---|---|
| FY23 | 28.30 | 7.20 | 28.30 |
| FY24 | 41.10 | 11.22 | 41.10 |
| FY25 | 70.30 | 13.37 | 70.30 |
11. How will the IPO proceeds be used?
Funds raised will be used for:
-
Setting up a nutraceutical facility – ₹22.60 Cr
-
Veterinary food division expansion – ₹11.59 Cr
-
Machinery for homecare and cosmetic units – ₹2.76 Cr
-
General corporate purposes
12. What are the risks involved with this IPO?
-
Overdependence on the nutraceutical industry
-
Geographical concentration in Maharashtra
-
Customer and supplier concentration risk
-
No long-term supplier contracts
-
Vulnerability to industry-specific and regional disruptions
13. Who are the IPO intermediaries?
-
Lead Manager: Rarever Financial Advisors Pvt. Ltd.
-
Registrar: Maashitla Securities Pvt. Ltd.
-
Market Maker: R.K. Stock Holding Pvt. Ltd.
14. What is the GMP of Influx Healthtech IPO?
The latest GMP of the Influx Healthtech IPO is ₹45.
Influx Healthtech IPO – Conclusion
Influx Healthtech IPO offers investors to invest in India’s growing nutraceutical and cosmetic manufacturing sector. The company has consistent revenue growth, a diversified portfolio, and plans to use IPO funds to expand capacity. However, investors should also consider the risks mentioned above before taking the plunge.
For investors with a medium to long-term outlook and a moderate risk appetite, this IPO could be a compelling addition to a diversified SME portfolio.
